Delivery Order SPE2DB22D3004-SPE2DB25FQU31

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,088.25, is for the delivery of 0.5 ML PEDIARIX syringes. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. The contract is not set-aside and was open to full and open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $7,866.10. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,573.49 firm-fixed-price contract is for the supply of 0.5 mL PEDIARIX syringes. The contract has an ultimate completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML syringes. The contract has a ceiling value of $7,777.66 and an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $3,894.64 and a completion date of July 30, 2024. The contract is a firm-fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor in the United States, has been awarded numerous...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $3,402.40 and a period of performance through March 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE, a vaccine product, at a ceiling value of $5,846.96. The contract has an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $4,727.96, is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML to support U.S. military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,363.82, is for the supply of PEDIARIX 0.5 ML SYRINGE 0.0.5ML, a pediatric vaccine. The contract has an ultimate completion date of October 2, 2023 and is a Firm Fixed Price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This $29,333 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The delivery order has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. This award is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQU31
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price of $7,649.16 and a completion date of May 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of medical products and supplies to military healthcare programs through December 2026. The contract is not designated as a set-aside.

Generated 8/20/25, 9:57 AM